Gold price today: Gold April futures surge above Rs 86,000/10 gm mark – here’s the outlook on the yellow metal – The Times of India

Gold price today: Gold April futures surge above Rs 86,000/10 gm mark – here’s the outlook on the yellow metal – The Times of India

Gold price: International precious metals prices strengthened, with gold reaching historic peak. (AI image) Gold price today: Gold April futures on MCX soared beyond Rs 86,000/10 gram, with the precious metal beginning Tuesday at a fresh peak of Rs 86,350 per 10 grams, showing a rise of 0.62% or Rs 534.Silver March futures were up…

Read More
New Income Tax Bill may be tabled by FM Sitharaman in Parliament today – Top points taxpayers should know – The Times of India

New Income Tax Bill may be tabled by FM Sitharaman in Parliament today – Top points taxpayers should know – The Times of India

The Union Cabinet approved the New Income Tax Bill on Friday. New Income Tax Bill LIVE: Finance Minister Nirmala Sitharaman may table the New Income Tax Bill in the Parliament on Tuesday. The intention to introduce the New Income Tax Bill was first announced by FM Sitharaman in her Union Budget 2025 speech.The Union Cabinet…

Read More
Government eyes 0 billion FDI as it sets up EFTA platform – The Times of India

Government eyes $100 billion FDI as it sets up EFTA platform – The Times of India

NEW DELHI: With an eye on receiving $100 billion investment from European Free Trade Association (EFTA) nations – Switzerland, Norway, Iceland and Liechtenstein – government on Monday announced the setting up of a dedicated platform to promote trade, investment and business facilitation between the two regions.Last March, India and the four European nations had signed…

Read More
Biocon’s growth formula: Generics & biosimilars – The Times of India

Biocon’s growth formula: Generics & biosimilars – The Times of India

BENGALURU: Biocon is betting big on new product launches in its generics and biosimilars portfolios, which are expected to fuel its expansion in the next 2-3 years. The company is leveraging the Viatris acquisition to provide a significant boost towards an integrated biosimilars enterprise model.This integrated approach encompasses complete oversight of value-generation through development and…

Read More